152 related articles for article (PubMed ID: 38464007)
1. Knockdown siRNA targeting GPR55 reveals significant differences between the anti-inflammatory actions of KLS-13019 and cannabidiol.
Brenneman DE; Kinney WA; McDonnell ME; Ippolito MJ; Ward SJ
Res Sq; 2024 Feb; ():. PubMed ID: 38464007
[TBL] [Abstract][Full Text] [Related]
2. Knockdown siRNA Targeting GPR55 Reveals Significant Differences Between the Anti-inflammatory Actions of KLS-13019 and Cannabidiol.
Brenneman DE; Kinney WA; McDonnell ME; Ippolito MJ; Ward SJ
J Mol Neurosci; 2024 Apr; 74(2):41. PubMed ID: 38602576
[TBL] [Abstract][Full Text] [Related]
3. Anti-Inflammatory Properties of KLS-13019: a Novel GPR55 Antagonist for Dorsal Root Ganglion and Hippocampal Cultures.
Brenneman DE; Kinney WA; McDonnell ME; Zhao P; Abood ME; Ward SJ
J Mol Neurosci; 2022 Sep; 72(9):1859-1874. PubMed ID: 35779192
[TBL] [Abstract][Full Text] [Related]
4. Knockdown siRNA Targeting the Mitochondrial Sodium-Calcium Exchanger-1 Inhibits the Protective Effects of Two Cannabinoids Against Acute Paclitaxel Toxicity.
Brenneman DE; Kinney WA; Ward SJ
J Mol Neurosci; 2019 Aug; 68(4):603-619. PubMed ID: 31077084
[TBL] [Abstract][Full Text] [Related]
5. Behavioural and pharmacological effects of cannabidiol (CBD) and the cannabidiol analogue KLS-13019 in mouse models of pain and reinforcement.
Foss JD; Farkas DJ; Huynh LM; Kinney WA; Brenneman DE; Ward SJ
Br J Pharmacol; 2021 Aug; 178(15):3067-3078. PubMed ID: 33822373
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol and mitragynine exhibit differential interactive effects in the attenuation of paclitaxel-induced mechanical allodynia, acute antinociception, and schedule-controlled responding in mice.
Ortiz YT; Bilbrey JA; Felix JS; Kienegger EA; Mottinelli M; Mukhopadhyay S; McCurdy CR; McMahon LR; Wilkerson JL
Pharmacol Rep; 2023 Aug; 75(4):937-950. PubMed ID: 37243887
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Comparisons Between Cannabidiol and KLS-13019.
Brenneman DE; Petkanas D; Kinney WA
J Mol Neurosci; 2018 Sep; 66(1):121-134. PubMed ID: 30109468
[TBL] [Abstract][Full Text] [Related]
8. CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain.
Krukowski K; Eijkelkamp N; Laumet G; Hack CE; Li Y; Dougherty PM; Heijnen CJ; Kavelaars A
J Neurosci; 2016 Oct; 36(43):11074-11083. PubMed ID: 27798187
[TBL] [Abstract][Full Text] [Related]
9. GPR55: A therapeutic target for Parkinson's disease?
Celorrio M; Rojo-Bustamante E; Fernández-Suárez D; Sáez E; Estella-Hermoso de Mendoza A; Müller CE; Ramírez MJ; Oyarzábal J; Franco R; Aymerich MS
Neuropharmacology; 2017 Oct; 125():319-332. PubMed ID: 28807673
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy.
Ward SJ; McAllister SD; Kawamura R; Murase R; Neelakantan H; Walker EA
Br J Pharmacol; 2014 Feb; 171(3):636-45. PubMed ID: 24117398
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice.
Tonello R; Lee SH; Berta T
J Pain; 2019 May; 20(5):515-527. PubMed ID: 30471427
[TBL] [Abstract][Full Text] [Related]
12. Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy.
Zhang H; Li Y; de Carvalho-Barbosa M; Kavelaars A; Heijnen CJ; Albrecht PJ; Dougherty PM
J Pain; 2016 Jul; 17(7):775-86. PubMed ID: 26979998
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats.
Ledeboer A; Jekich BM; Sloane EM; Mahoney JH; Langer SJ; Milligan ED; Martin D; Maier SF; Johnson KW; Leinwand LA; Chavez RA; Watkins LR
Brain Behav Immun; 2007 Jul; 21(5):686-98. PubMed ID: 17174526
[TBL] [Abstract][Full Text] [Related]
14. Phosphosulindac (OXT-328) prevents and reverses chemotherapy induced peripheral neuropathy in mice.
Basu A; Yang JY; Tsirukis VE; Loiacono A; Koch G; Khwaja IA; Krishnamurthy M; Fazio N; White E; Jha A; Shah S; Takmil C; Bagdas D; Demirer A; Master A; Natke E; Honkanen R; Huang L; Rigas B
Front Neurosci; 2023; 17():1240372. PubMed ID: 38347876
[TBL] [Abstract][Full Text] [Related]
15. Cellular distribution of cannabinoid-related receptors TRPV1, PPAR-gamma, GPR55 and GPR3 in the equine cervical dorsal root ganglia.
Galiazzo G; De Silva M; Giancola F; Rinnovati R; Peli A; Chiocchetti R
Equine Vet J; 2021 Aug; 54(4):788-98. PubMed ID: 34418142
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome analysis reveals dysregulation of inflammatory and neuronal function in dorsal root ganglion of paclitaxel-induced peripheral neuropathy rats.
Sun W; Yang S; Wu S; Ba X; Xiong D; Xiao L; Hao Y
Mol Pain; 2023; 19():17448069221106167. PubMed ID: 35610945
[TBL] [Abstract][Full Text] [Related]
17. Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice.
Kume M; Ahmad A; DeFea KA; Vagner J; Dussor G; Boitano S; Price TJ
J Pain; 2023 Nov; 24(11):1980-1993. PubMed ID: 37315729
[TBL] [Abstract][Full Text] [Related]
18. Role of pattern recognition receptors in chemotherapy-induced neuropathic pain.
Araldi D; Khomula EV; Bonet IJM; Bogen O; Green PG; Levine JD
Brain; 2024 Mar; 147(3):1025-1042. PubMed ID: 37787114
[TBL] [Abstract][Full Text] [Related]
19. GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis.
Kargl J; Andersen L; Hasenöhrl C; Feuersinger D; Stančić A; Fauland A; Magnes C; El-Heliebi A; Lax S; Uranitsch S; Haybaeck J; Heinemann A; Schicho R
Br J Pharmacol; 2016 Jan; 173(1):142-54. PubMed ID: 26436760
[TBL] [Abstract][Full Text] [Related]
20. The Cannabidiol Analog PECS-101 Prevents Chemotherapy-Induced Neuropathic Pain via PPARγ Receptors.
Silva NR; Gomes FIF; Lopes AHP; Cortez IL; Dos Santos JC; Silva CEA; Mechoulam R; Gomes FV; Cunha TM; Guimarães FS
Neurotherapeutics; 2022 Jan; 19(1):434-449. PubMed ID: 34904193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
